Gennex Laboratories Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 930938,
    "name": "Gennex Lab.",
    "stock_name": "Gennex Lab.",
    "full_name": "Gennex Laboratories Ltd",
    "name_url": "stocks-analysis/gennex-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "10.67",
    "chg": 0.23,
    "chgp": "2.2%",
    "dir": 1,
    "prev_price": "10.44",
    "mcapval": "260.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531739,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE509C01026",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "3.2 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/gennex-lab-930938-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Gennex Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-gennex-laboratories-ltd-4001748",
        "imagepath": "",
        "date": "2026-05-20 23:19:00",
        "description": "The next results date for Gennex Laboratories Ltd is scheduled for 30 May 2026...."
      },
      {
        "title": "Gennex Laboratories Ltd Valuation Turns Very Attractive Amid Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-valuation-turns-very-attractive-amid-market-pressure-3997830",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GennexLaborator_valuationdot_3997830.png",
        "date": "2026-05-19 08:01:56",
        "description": "Gennex Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a significant shift in its valuation parameters, moving from an attractive to a very attractive rating. Despite recent share price declines and underperformance relative to the Sensex, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present compelling value compared to peers and historical averages."
      },
      {
        "title": "Gennex Laboratories Ltd Valuation Shifts to Very Attractive Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-valuation-shifts-to-very-attractive-amid-sector-challenges-3988496",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GennexLaborator_valuationdot_3988496.png",
        "date": "2026-05-13 08:01:21",
        "description": "Gennex Laboratories Ltd has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating, despite ongoing challenges in its stock price performance relative to the broader market. This micro-cap pharmaceutical player’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a compelling entry point compared to its historical averages and peer group benchmarks."
      },
      {
        "title": "Gennex Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-is-rated-sell-3979644",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GennexLaborator_mojoScore_3979644.png",
        "date": "2026-05-07 10:10:03",
        "description": "Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Gennex Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-is-rated-sell-3963193",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GennexLaborator_mojoScore_3963193.png",
        "date": "2026-04-26 10:10:02",
        "description": "Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Gennex Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-is-rated-sell-3947415",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GennexLaborator_mojoScore_3947415.png",
        "date": "2026-04-15 10:10:03",
        "description": "Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Gennex Laboratories Ltd: Valuation Shift Enhances Price Attractiveness Amid Mixed Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-valuation-shift-enhances-price-attractiveness-amid-mixed-returns-3933679",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GennexLaborator_valuationdot_3933679.png",
        "date": "2026-04-06 08:01:15",
        "description": "Gennex Laboratories Ltd has witnessed a notable improvement in its valuation parameters, shifting from very attractive to attractive territory, driven primarily by a subdued price-to-earnings (P/E) ratio and price-to-book value (P/BV) metrics. Despite this positive valuation shift, the company’s stock performance over recent months and years presents a mixed picture when compared to broader market benchmarks such as the Sensex."
      },
      {
        "title": "Markets Rally, But Gennex Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-stock-falls-to-52-week-low-of-rs806-3916038",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3916038.png",
        "date": "2026-03-25 10:48:35",
        "description": "Despite a broad market upswing, Gennex Laboratories Ltd has slipped to a fresh 52-week low of Rs 8.06 on 25 Mar 2026, marking a near 53% decline from its 52-week high of Rs 17.25. This divergence from the market rally highlights persistent headwinds for the micro-cap pharmaceutical player."
      },
      {
        "title": "Gennex Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-is-rated-sell-3909891",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_mojoScore_3909891.png",
        "date": "2026-03-24 10:10:02",
        "description": "Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 15,
    "sid": "930938",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/gennex-laboratories-930938"
  },
  "announcements": [
    {
      "caption": "Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.",
      "datetime": "10-Jun-2026",
      "details": "The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on June 10 2026 for Premier Fiscal Services Pvt Ltd",
      "source": "BSE"
    },
    {
      "caption": "Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.",
      "datetime": "10-Jun-2026",
      "details": "The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on June 10 2026 for Premier Fiscal Services Pvt Ltd",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
      "datetime": "10-Jun-2026",
      "details": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on June 10 2026 for Premier Fiscal Services Pvt Ltd",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Gennex Laboratories Ltd has announced <strong>1:10</strong> stock split, ex-date: 14 Dec 09",
          "dt": "2009-12-14",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Gennex Laboratories Ltd has announced <strong>1:2</strong> rights issue, ex-date: 21 Jul 22",
          "dt": "2022-07-21",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

When is the next results date for Gennex Laboratories Ltd?

2026-05-20 23:19:00

The next results date for Gennex Laboratories Ltd is scheduled for 30 May 2026....

Gennex Laboratories Ltd Valuation Turns Very Attractive Amid Market Pressure

2026-05-19 08:01:56

Gennex Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a significant shift in its valuation parameters, moving from an attractive to a very attractive rating. Despite recent share price declines and underperformance relative to the Sensex, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present compelling value compared to peers and historical averages.

Gennex Laboratories Ltd Valuation Shifts to Very Attractive Amid Sector Challenges

2026-05-13 08:01:21

Gennex Laboratories Ltd has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating, despite ongoing challenges in its stock price performance relative to the broader market. This micro-cap pharmaceutical player’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a compelling entry point compared to its historical averages and peer group benchmarks.

Gennex Laboratories Ltd is Rated Sell

2026-05-07 10:10:03

Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Gennex Laboratories Ltd is Rated Sell

2026-04-26 10:10:02

Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Gennex Laboratories Ltd is Rated Sell

2026-04-15 10:10:03

Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Gennex Laboratories Ltd: Valuation Shift Enhances Price Attractiveness Amid Mixed Returns

2026-04-06 08:01:15

Gennex Laboratories Ltd has witnessed a notable improvement in its valuation parameters, shifting from very attractive to attractive territory, driven primarily by a subdued price-to-earnings (P/E) ratio and price-to-book value (P/BV) metrics. Despite this positive valuation shift, the company’s stock performance over recent months and years presents a mixed picture when compared to broader market benchmarks such as the Sensex.

Markets Rally, But Gennex Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-25 10:48:35

Despite a broad market upswing, Gennex Laboratories Ltd has slipped to a fresh 52-week low of Rs 8.06 on 25 Mar 2026, marking a near 53% decline from its 52-week high of Rs 17.25. This divergence from the market rally highlights persistent headwinds for the micro-cap pharmaceutical player.

Gennex Laboratories Ltd is Rated Sell

2026-03-24 10:10:02

Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 March 2026, providing investors with the latest insights into the company’s performance and outlook.

View All News